Press Releases

Certara’s Synchrogenix Unit Provides Solution to Enable Pharma Compliance with EMA Policy 70

March 24, 2016

Newly-released guidance points to need for automated and scalable redaction technology

Read more

Certara Scientists to Participate in 12 Sessions at the ASCPT 2016 Annual Meeting

March 04, 2016

At ASCPT, Certara scientists will demonstrate how physiologically-based pharmacokinetic and pharmacodynamic modeling can help determine appropriate drug dosing in vulnerable populations and will also provide examples of using Model-Based Meta-Analysis to study the comparative effectiveness of different treatments

Read more

Certara Introduces Phoenix Technology Services to Optimize Pharma R&D Productivity

February 25, 2016

New Services Portfolio Supports Users of Certara’s Gold Standard Phoenix Software

Read more

Certara Expands Its Quantitative Systems Pharmacology Group; Appoints Professor Andrzej Kierzek

February 03, 2016

Certara established its market-leading position in QSP with the acquisition of XenologiQ, a UK-based QSP consultancy, in December 2015.

Read more

Japan Workshop August 2016

January 20, 2016

Drug development based on the information obtained from the central workshop physiological pharmacokinetic (PBPK ) Mode

Read more

Certara Launches a Strategic Drug Development Consulting Company in China

January 12, 2016

New company will use the full range of its modeling and simulation expertise to make the drug development process safer and more efficient

Read more

Certara Honored with 2015 R&D 100 Award for Its Muse Invent Software

December 14, 2015

Muse Invent enables biopharm researchers to design dream drug candidates, and then shows how to produce them in the lab

Read more

Certara Launches Version 15 of its Simcyp Population-based Simulator

December 08, 2015

Simcyp Simulator helps advance drug development and regulatory approval for the world’s top pharma companies

Read more

Certara Acquires Quantitative Systems Pharmacology Consultancy, XenologiQ

December 01, 2015

This transaction will strengthen Certara’s biosimulation capabilities, allowing it to link biological systems and disease processes

Read more

Certara Appoints Prof. Piet van der Graaf to Lead New Quantitative Systems Pharmacology Organization

December 01, 2015

Van der Graaf is professor of systems pharmacology, chair of pharmacology, and director of the Leiden Academic Centre for Drug Research at Leiden University in the Netherlands.

Read more

FDA Equips its Pharmacometrics Teams with Certara’s Phoenix Software

November 02, 2015

Partnership provides pharmacometric biosimulation solutions for multiple FDA centers

Read more

Certara Scientists to Give 22 Presentations at the AAPS Annual meeting

October 22, 2015

Their contributions include workshops, symposia, roundtables, posters, and a sunrise session

Read more

Japanese Medical Research and Development Agency Selects Phoenix WinNonlin Software

October 20, 2015

AMED was launched on April 1, 2015 and fulfills a similar role to the National Institutes of Health in the United States

Read more

Certara Scientists Participate in 9 Presentations at the North American ISSX Meeting

October 19, 2015

Diverse agenda underscores the widespread adoption of PBPK approaches throughout the drug development process

Read more

Certara Joins EU-ToxRisk – A Program Driving Mechanism-based Toxicity Testing and Risk Assessment

October 12, 2015

In a large (30 Million €) H2020-supported collaborative project, academia joins forces with small and medium-sized enterprises (SMEs), large industry, contract research organizations (CROs) and regulatory bodies to achieve a paradigm shift in toxicology towards a more efficient and animal-free chemical safety assessment.

Read more

Certara Scientists Participate in 14 Presentations at 6th American Conference on Pharmacometrics

October 02, 2015

Diverse agenda underscores the widespread adoption of pharmacometrics throughout the drug development process

Read more

Certara Presents Tuberculosis Biomarker Meta-Analysis and Pediatric Antibiotic Model at ASM

September 25, 2015

Certara presented two posters at the American Society for Microbiology’s (ASM’s) Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC).

Read more

Certara and Paidion Research Form Partnership Focused on Improving Pediatric Drug Development

September 10, 2015

The partnership harnesses Certara’s unmatched biosimulation (modeling and simulation) and regulatory writing capabilities, with Paidion’s regulatory strategy and pediatric clinical trial management expertise to address the critical challenges of bringing new therapies to children.

Read more

Certara Pharmacometrician Receives Faculty Appointment at University of Montreal

August 27, 2015

In this new role, Dr. Samer Mouksassi will teach clinicians and students how biosimulation can be used to improve drug development and enhance health outcomes.

Read more

 1 2 3 >  Last ›